Article
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
14 Jun 2021
Abstract excerpt
Background The therapeutic efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced EGFR-mutant lung squamous cell carcinoma (SCC) patients remains uncertain. Furthermore, the factors underlying the responsiveness have not been fully investigated. We therefore investigated the link between genomic profiles and EGFR-TKI efficacy. Material and Methods We consecutively enrolled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
